Surgical Merits of Open, Laparoscopic, and Robotic Gastrectomy Techniques with D2 Lymphadenectomy in Obese Patients with Gastric Cancer

被引:28
作者
Choi, Seohee [1 ]
Song, Jeong Ho [2 ,3 ]
Lee, Sejin [2 ,3 ]
Cho, Minah [2 ,3 ,4 ]
Kim, Yoo Min [2 ,3 ,4 ]
Hyung, Woo Jin [2 ,3 ,4 ]
Kim, Hyoung-Il [2 ,3 ,4 ]
机构
[1] Eulji Univ, Eulji Gen Hosp, Dept Surg, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Dept Surg, Coll Med, Seoul, South Korea
[3] Yonsei Univ Hlth Syst, Gastr Canc Ctr, Yonsei Canc Ctr, Seoul, South Korea
[4] Yonsei Univ Hlth Syst, Severance Hosp, Robot & MIS Ctr, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
ASSISTED DISTAL GASTRECTOMY; LYMPH-NODE DISSECTION; SHORT-TERM OUTCOMES; QUALITY-CONTROL; VISCERAL FAT; COMPLICATIONS; IMPACT;
D O I
10.1245/s10434-021-09952-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Robotic surgery has been widely adopted for complex procedures to overcome technical limitations of open or laparoscopic methods. However, evidence of any subsequent benefit is lacking. This study was undertaken to compare open, laparoscopic, and robotic gastrectomy in technically demanding procedure-D2 dissection in obese patients with gastric cancer. Methods Data collected between 2010 and 2018 on D2 gastrectomy in obese patients with gastric cancer were used to conduct retrospective analysis, comparing short- and long-term outcomes of open, laparoscopic, and robotic techniques. Results In a total of 185 patients, there were 69 open, 62 laparoscopic, and 54 robotic gastrectomy procedures. Median ages for respective surgical groups were 66 (interquartile range [IQR]: 61-64 years), 63 (IQR: 59-63), and 59 years (IQR: 56-60 years) (p = 0.009). Early-stage gastric cancer ranked proportionately higher in the laparoscopic group (p = 0.005), but operative times were similar among groups. Estimated blood loss (p < 0.001) and drainage volumes (p = 0.001) were higher in the open group, relative to others. Although a robotic approach performed best in overall compliance and in mean number of retrieved lymph node, observed rates of early or late complications did not differ by technique. The open group experienced significantly poorer overall (p = 0.039) and relapse-free (p < 0.001) survival compared with the laparoscopic or robotic group. Robotic surgery emerged from multivariable Cox regression as a protective factor for relapse-free survival (HR = 0.314, 95% CI 0.116-0.851). Conclusions In obese patients with gastric cancer, robotic gastrectomy with D2 lymphadenectomy proved comparable to open or laparoscopic technique short-term, yielding better long-term outcomes.
引用
收藏
页码:7051 / 7060
页数:10
相关论文
共 29 条
[1]   Lower rate of conversion using robotic-assisted surgery compared to laparoscopy in completion total gastrectomy for remnant gastric cancer [J].
Alhossaini, Rana M. ;
Altamran, Abdulaziz A. ;
Cho, Minah ;
Roh, Chul Kyu ;
Seo, Won Jun ;
Choi, Seohee ;
Son, Taeil ;
Kim, Hyoung-Il ;
Hyung, Woo Jin .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2020, 34 (02) :847-852
[2]  
Amin MB., 2017, AJCC Cancer Staging Manual, Ved 8
[3]   Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial [J].
Claassen, Yvette H. M. ;
de Steur, Wobbe O. ;
Hartgrink, Henk H. ;
Dikken, Johan L. ;
van Sandick, Johanna W. ;
van Grieken, Nicole C. T. ;
Cats, Annemiek ;
Trip, Anouk K. ;
Jansen, Edwin P. M. ;
Kranenbarg, Willemina M. Meershoek-Klein ;
Braak, Jeffrey P. B. M. ;
Putter, Hein ;
Henegouwen, Mark I. van Berge ;
Verhetj, Marcel ;
van de Velde, Cornelis J. H. .
ANNALS OF SURGERY, 2018, 268 (06) :1008-1013
[4]   Quality control of lymph node dissection in the Dutch Gastric Cancer Trial [J].
de Steur, W. O. ;
Hartgrink, H. H. ;
Dikken, J. L. ;
Putter, H. ;
van de Velde, C. J. H. .
BRITISH JOURNAL OF SURGERY, 2015, 102 (11) :1388-1393
[5]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[6]   Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial [J].
Fujitani, Kazumasa ;
Yang, Han-Kwang ;
Mizusawa, Junki ;
Kim, Young-Woo ;
Terashima, Masanori ;
Han, Sang-Uk ;
Iwasaki, Yoshiaki ;
Hyung, Woo Jin ;
Takagane, Akinori ;
Park, Do Joong ;
Yoshikawa, Takaki ;
Hahn, Seokyung ;
Nakamura, Kenichi ;
Park, Cho Hyun ;
Kurokawa, Yukinori ;
Bang, Yung-Jue ;
Park, Byung Joo ;
Sasako, Mitsuru ;
Tsujinaka, Toshimasa .
LANCET ONCOLOGY, 2016, 17 (03) :309-318
[7]   Parameters for Predicting Surgical Outcomes for Gastric Cancer Patients: Simple Is Better Than Complex [J].
Guner, Ali ;
Kim, Sang Yong ;
Yu, Jae Eun ;
Min, In Kyung ;
Roh, Yun Ho ;
Roh, Chulkyu ;
Seo, Won Jun ;
Cho, Minah ;
Choi, Seohee ;
Choi, Yoon Young ;
Son, Taeil ;
Cheong, Jae-Ho ;
Hyung, Woo Jin ;
Noh, Sung Hoon ;
Kim, Hyoung-Il .
ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (11) :3239-3247
[8]   Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial [J].
Hyung, Woo Jin ;
Yang, Han-Kwang ;
Park, Young-Kyu ;
Lee, Hyuk-Joon ;
An, Ji Yeong ;
Kim, Wook ;
Kim, Hyoung-Il ;
Kim, Hyung-Ho ;
Ryu, Seung Wan ;
Hur, Hoon ;
Kim, Min-Chan ;
Kong, Seong-Ho ;
Cho, Gyu Seok ;
Kim, Jin-Jo ;
Park, Do Joong ;
Ryu, Keun Won ;
Kim, Young Woo ;
Kim, Jong Won ;
Lee, Joo-Ho ;
Han, Sang-Uk .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (28) :3304-3313
[9]   A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901) [J].
Inaki, Noriyuki ;
Etoh, Tsuyoshi ;
Ohyama, Tetsuji ;
Uchiyama, Kazuhisa ;
Katada, Natsuya ;
Koeda, Keisuke ;
Yoshida, Kazuhiro ;
Takagane, Akinori ;
Kojima, Kazuyuki ;
Sakuramoto, Shinichi ;
Shiraishi, Norio ;
Kitano, Seigo .
WORLD JOURNAL OF SURGERY, 2015, 39 (11) :2734-2741
[10]   Japanese gastric cancer treatment guidelines 2018 (5th edition) [J].
Japanese Gastric Cancer Association .
GASTRIC CANCER, 2021, 24 (01) :1-21